FindTrial
Sign In

The effect of Glycan-based Biomarkers for Diagnosis of sepsis

The effect of Glycan-based Biomarkers for Diagnosis of sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021462
Enrollment
Unknown
Registered
2019-02-22
Start date
2019-02-28
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Gold Standard:clinical manifestation of infection and the Etiological Evidence
Index test:Man,&#32
GLCN,&#32
galn,&#32
glcua,&#32
GLC,&#32
GAL,&#32
XYL,&#32
FUC

Sponsors

the Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newly admitted ICU patients

Exclusion criteria

Exclusion criteria: age <18years

Design outcomes

Primary

MeasureTime frame
Man;GLCN;galn;glcua;GLC;GAL;XYL;FUC;—

Countries

China

Contacts

Public ContactBO Yao

the Affiliated Hospital of Qingdao University

icuyaobo@126.com+86 0532 829122220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026